JPRN-UMIN000014922
Completed
N/A
Effect of Dapagliflozin in patients with type 2 daibetes mellitus - Effect of Dapagliflozin in patients with type 2 daibetes mellitus
ConditionsType 2 diabetes mellitus
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus
- Sponsor
- Iwasaki Naika Clinic
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Type 1 diabetes 2\. Patients with severe renal failure or liver dysfunction 3\. Patients with drug allergy for ipraglifrozin 4\. Patients with history of diabetec ketosis 5\. Patients with shick day
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
Recruiting
Phase 2
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unitDiabetesMetabolic and Endocrine - DiabetesACTRN12621001102864Austin Health40
Completed
N/A
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
Active, Not Recruiting
N/A
Impact of treatment with Dapagliflozin in type 1 diabetic patientsEUCTR2015-002963-40-ESDra Cristina Avendaño Sola
Not Yet Recruiting
Phase 4
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160